MONOPTY 122016Recalls & reported problems
Bard Peripheral Vascular, Inc. · MONOPTY® Disposable Core Biopsy Instrument, 22mm penetration depth, 20g x 16cm · Class 2
All models of MONOPTY (13)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00801741084676), received between Jul 11, 2019 and Nov 9, 2020 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Self-Activation or Keying” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Self-Activation or Keying1
Patient problems
- Hematuria1
- Hemorrhage/Blood Loss/Bleeding1
- No Consequences Or Impact To Patient1
- Pseudoaneurysm1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryNov 9, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THROUGH A POST-MARKET CLINICAL FOLLOW-UP SURVEY ON CORE BIOPSY INSTRUMENTS, THERE WAS 1 OCCURRENCE OF HEMORRHAGE, AND 2 OCCURRENCES OF BLEEDING, ONE REQUIRING INTERVENTION, DURING LIVER BIOPSY PROCEDURE(S). IT WAS FURTHER REPORTED THERE WERE 3 OCCURRENCES OF HEMATURIA, 1 OCCURRENCE OF PSEUDOANEURYSM, AND 3 OCCURRENCES OF BLEEDING, TWO REQUIRING INTERVENTION, DURING KIDNEY BIOPSY PROCEDURE(S). THE CURRENT STATUS OF THE PATIENT(S) WAS NOT PROVIDED.
Patient problems: Hematuria; Hemorrhage/Blood Loss/Bleeding; Pseudoaneurysm
MAUDE report 10808534 ↗MalfunctionJul 11, 2019Self-Activation or Keying; Self-Activation or Keying
THIS REPORT SUMMARIZES ONE (1) MALFUNCTION. A REVIEW OF THE REPORTED INFORMATION INDICATED THAT MODEL 122016 BIOPSY INSTRUMENT ALLEGEDLY EXPERIENCED SELF-ACTIVATION. THIS INFORMATION WAS RECEIVED FROM ONE SOURCE. THE MALFUNCTION INVOLVED A PATIENT WITH NO KNOWN IMPACT TO THE PATIENT. THE MALE PATIENT'S AGE AND WEIGHT WERE NOT PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8783142 ↗
Other INSTRUMENT, BIOPSY devices
- MAX-CORE MC1616Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall4,258 reports
- ENCOR® ECP017GSenorx, Inc. · INSTRUMENT, BIOPSY1 recall4,186 reports
- MAX-CORE MC1820Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall2,404 reports
- MAX-CORE MC1816Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall1 death848 reports
- MAX-CORE MC1410Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall399 reports
- MAX-CORE MC1610Bard Peripheral Vascular, Inc. · INSTRUMENT, BIOPSY1 recall394 reports
- ENCOR® ECP0110GVSenorx, Inc. · INSTRUMENT, BIOPSY392 reports
- ENCOR® ECP0110GSenorx, Inc. · INSTRUMENT, BIOPSY390 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page